We’ve recently updated our valuation analysis.

Pfizer Valuation

Is 500680 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 500680?

Other financial metrics that can be useful for relative valuation.

500680 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue7.6x
Enterprise Value/EBITDA26.6x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 500680's PE Ratio compare to its peers?

500680 PE Ratio vs Peers
The above table shows the PE ratio for 500680 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average39.8x
524494 Ipca Laboratories
32.8x23.3%₹236.0b
500660 GlaxoSmithKline Pharmaceuticals
61.2x14.4%₹238.6b
AJANTPHARM Ajanta Pharma
23x13.6%₹164.4b
506943 J. B. Chemicals & Pharmaceuticals
42x24.7%₹156.2b
500680 Pfizer
45.2xn/a₹201.4b

Price-To-Earnings vs Peers: 500680 is expensive based on its Price-To-Earnings Ratio (45.2x) compared to the peer average (39.8x).


Price to Earnings Ratio vs Industry

How does 500680's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

Price-To-Earnings vs Industry: 500680 is expensive based on its Price-To-Earnings Ratio (45.2x) compared to the Indian Pharmaceuticals industry average (24.1x)


Price to Earnings Ratio vs Fair Ratio

What is 500680's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

500680 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio45.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 500680's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 500680 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 500680 (₹4401.45) is trading above our estimate of fair value (₹3168.59)

Significantly Below Fair Value: 500680 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies